Anavex Life Sciences Corp (AVXL)

[nidan7500]

FINALLY...

Greicius, who is the Iqbal Farrukh and Asad Jamal Professor and the former director of the Stanford Center for Memory Disorders, thinks all three plaque-attack drugs are "decidedly underwhelming." Not because they fail to reduce plaque, Greicius said, but in spite of their success in doing so.
The three drugs attack plaque at somewhat different stages of its formation but are all meant to remove these deposits from the brain. And this they undoubtedly do.

"All are quite adept at pulling amyloid plaques out of the brain," Greicius said. "But none of these drugs makes much of a difference to the patient's wellbeing. The effect is tiny."

None of these drugs makes much of a difference to the patient's wellbeing. The effect is tiny.

From Stanford

One step back: Why the new Alzheimer’s plaque-attack drugs don’t work

https://scopeblog.stanford.edu/2024/03/13/why-alzheimers-plaque-attack-drugs-dont-work/

As W.E. Deming has famously said..."The first step in solving a problem is acknowledging that one actually exists."

NOW, can we all just move on. Remember, these insider leaders are the same people who decide where the tax payer research $$$ gets spent. Will they now investigate why (after decades of obviously poor leadership) they never recognized they were just WRONG ??

So, as uncomfortable as it might be someone must declare an end to FDA-NIH-etc. Amyloid AD and MOVE ON.
.

We will know it when we see it.